nach oben

Erschienen in:

01.06.2023 | Media release

Advice on safe use of DOACs in children and patients with renal impairment

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Advice regarding the safe use of the new paediatric formulations of direct-acting oral anticoagulants (DOACs) and dose adjustments in adults with renal impairment is provided in the Drug Safety Update published by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK. …

Medicines and Healthcare products Regulatory Agency (UK). Direct-acting oral anticoagulants (DOACs): paediatric formulations; reminder of dose adjustments in patients with renal impairment. Internet Document : 25 May 2023. Available from: URL: https://www.gov.uk/drug-safety-update/direct-acting-oral-anticoagulants-doacs-paediatric-formulations-reminder-of-dose-adjustments-in-patients-with-renal-impairment

Titel: Advice on safe use of DOACs in children and patients with renal impairment
Publikationsdatum: 01.06.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-40830-3

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Advice on safe use of DOACs in children and patients with renal impairment

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Bevacizumab/nivolumab/toripalimab

Ipilimumab/nivolumab/pembrolizumab

Ampicillin/gentamicin

Fentanyl toxicity

Multiple drugs

Baricitinib